BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36933242)

  • 1. MicroRNA-362-3p Implicated in Cardioprotection Against Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis by Repressing TP53INP2 and Regulating SDF-1/CXCR4 Pathway.
    Shi J; Qin S; Wang R; Zhang Z; Li H; Hao C
    Altern Ther Health Med; 2023 Apr; 29(3):254-261. PubMed ID: 36933242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-668-3p Protects Against Oxygen-Glucose Deprivation in a Rat H9c2 Cardiomyocyte Model of Ischemia-Reperfusion Injury by Targeting the Stromal Cell-Derived Factor-1 (SDF-1)/CXCR4 Signaling Pathway.
    Gao Z; Gao Q; Lv X
    Med Sci Monit; 2020 Jan; 26():e919601. PubMed ID: 31997826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-210 aggravates hypoxia-induced injury in cardiomyocyte H9c2 cells by targeting CXCR4.
    Feng M; Li Z; Wang D; Wang F; Wang C; Wang C; Ding F
    Biomed Pharmacother; 2018 Jun; 102():981-987. PubMed ID: 29710553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-148b-3p is involved in regulating hypoxia/reoxygenation-induced injury of cardiomyocytes in vitro through modulating SIRT7/p53 signaling.
    Sun M; Zhai M; Zhang N; Wang R; Liang H; Han Q; Jia Y; Jiao L
    Chem Biol Interact; 2018 Dec; 296():211-219. PubMed ID: 30308185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA FTX alleviates hypoxia/reoxygenation-induced cardiomyocyte injury via miR-410-3p/Fmr1 axis.
    Li L; Li L; Zhang YZ; Yang HY; Wang YY
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):396-408. PubMed ID: 31957854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-1247-3p protects rat cardiomyocytes against hypoxia/reoxygenation-induced injury via targeting BCL2L11 and caspase-2.
    Huang J; Huang Y; Feng Z; Guo W; Wang X; Liao Z
    J Recept Signal Transduct Res; 2021 Feb; 41(1):6-14. PubMed ID: 32605511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircUBXN7 Impedes Apoptosis to Alleviate Myocardial Infarction Injury by Regulating the miR-582-3p/MARK3 Axis.
    Wang L; Liu X; Xia Z
    Ann Clin Lab Sci; 2023 Mar; 53(2):303-312. PubMed ID: 37094856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acid protects cardiomyocytes against hypoxia-induced injury through targeting MiR-210-3p/CASP8AP2 axis.
    Yu X; Liu F; Liu Y; Bai B; Yin H; Wang H; Feng Y; Ma H; Geng Q
    Mol Cell Biochem; 2021 Aug; 476(8):2999-3007. PubMed ID: 33791918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-17-3p protects against excessive posthypoxic autophagy in H9C2 cardiomyocytes via PTEN-Akt-mTOR signaling pathway.
    He Y; Zhang D; Zhang Q; Cai Y; Huang C; Xia Z; Wang S
    Cell Biol Int; 2023 May; 47(5):943-953. PubMed ID: 36934412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citrate pretreatment attenuates hypoxia/reoxygenation-induced cardiomyocyte injury via regulating microRNA-142-3p/Rac1 aix.
    Xiang H; Yang J; Li J; Yuan L; Lu F; Liu C; Tang Y
    J Recept Signal Transduct Res; 2020 Dec; 40(6):560-569. PubMed ID: 32456513
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoxia-elicited cardiac microvascular endothelial cell-derived exosomal miR-210-3p alleviate hypoxia/reoxygenation-induced myocardial cell injury through inhibiting transferrin receptor 1-mediated ferroptosis.
    Lei D; Li B; Isa Z; Ma X; Zhang B
    Tissue Cell; 2022 Dec; 79():101956. PubMed ID: 36272206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-362-3p Targets Orosomucoid 1 to Promote Cell Proliferation, Restrain Cell Apoptosis and Thereby Mitigate Hypoxia/Reoxygenation-Induced Cardiomyocytes Injury.
    Shi M; Ma X; Yang Q; Wang W; Li X; Song X; Li Y; Xie Y; Dang Y
    Cardiovasc Toxicol; 2021 May; 21(5):387-398. PubMed ID: 33459949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ-CBFB exacerbates hypoxia/reoxygenation-triggered cardiomyocyte injury via regulating miR-495-3p in a VDAC1-dependent manner.
    Chen YE; Yang H; Pang HB; Shang FQ
    J Biochem Mol Toxicol; 2022 Nov; 36(11):e23189. PubMed ID: 35920438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of miR-383-3p protects cardiomyocytes against hypoxia/reoxygenation injury via regulating PTEN/PI3K/AKT signal pathway.
    Zeng H; Li Y; Liu X; Li X; Zhou T; Cao S; Wang M; Ju M
    J Biochem Mol Toxicol; 2022 Dec; 36(12):e23205. PubMed ID: 36224710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rian/miR-210-3p/Nfkb1 Feedback Loop Promotes Hypoxia-Induced Cell Apoptosis in Myocardial Infarction Through Deactivating the PI3K/Akt Signaling Pathway.
    Zhong L; Jia J; Ye G
    J Cardiovasc Pharmacol; 2020 Aug; 76(2):207-215. PubMed ID: 32187165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-181c-5p Exacerbates Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis via Targeting PTPN4.
    Ge L; Cai Y; Ying F; Liu H; Zhang D; He Y; Pang L; Yan D; Xu A; Ma H; Xia Z
    Oxid Med Cell Longev; 2019; 2019():1957920. PubMed ID: 31178952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibited HDAC3 or Elevated MicroRNA-494-3p Plays a Protective Role in Myocardial Ischemia-Reperfusion Injury via Suppression of BRD4.
    Zheng W; Xie Q; Zhang Z; Li J; Fang L; Li W
    Mol Neurobiol; 2021 Sep; 58(9):4268-4279. PubMed ID: 33982231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-7a-5p Attenuates Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis by Targeting VDAC1.
    Lu H; Zhang J; Xuan F
    Cardiovasc Toxicol; 2022 Feb; 22(2):108-117. PubMed ID: 34661851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sevoflurane inhibits the apoptosis of hypoxia/reoxygenation-induced cardiomyocytes via regulating miR-27a-3p-mediated autophagy.
    Zhang Y; Zhan B; Hu Y; Chen S; Zhang Q
    J Pharm Pharmacol; 2021 Oct; 73(11):1470-1479. PubMed ID: 34383044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of miR-223-3p ameliorates hypoxia-induced injury through repressing cardiomyocyte apoptosis and oxidative stress by targeting KLF15.
    Tang Q; Li MY; Su YF; Fu J; Zou ZY; Wang Y; Li SN
    Eur J Pharmacol; 2018 Dec; 841():67-74. PubMed ID: 30336138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.